Connect with us

Technology

Molecular Instruments and Visiopharm Announce Strategic Partnership to Combine AI-Driven Precision Pathology with HCR™ Pro Assays to Advance Clinical-Grade RNA-ISH

Published

on

LOS ANGELES, Nov. 6, 2024 /PRNewswire/ — Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, is pleased to announce a strategic partnership with Visiopharm, a global leader in AI-driven precision pathology software. This collaboration brings together MI’s clinical-grade HCR™ platform with Visiopharm’s Oncotopix® Discovery software, empowering users with a highly flexible, deep learning approach to precise and efficient image analysis for RNA-ISH assays.

MI’s class-leading HCR™ Pro RNA-ISH assay, lauded for making protease-free sample preparation the standard for RNA-ISH, provides unparalleled specificity and sensitivity in RNA detection and enables seamless integration with existing IHC/IF workflows. When combined with Oncotopix® Discovery, researchers can analyze chromogenic and fluorescent HCR™ Pro RNA-ISH and HCR™ Pro RNA-ISH + IHC/IF co-detection images with more precise segmentation and spot counting, ensuring accurate gene expression profiling in even the most challenging samples.

“Our North Star at MI is to set bioimaging assays to a true ‘clinical-grade’ standard, focusing on performance, robustness, and accessibility,” said Dr. Aneesh Acharya, Chief Commercial Officer at Molecular Instruments. “Partnering with Visiopharm reflects our shared drive to delivering clinical-grade assays, paired with world-class analysis tools that empower pathologists and support downstream decision-making. We’re thrilled to kickstart this journey with the team at Visiopharm to bring new possibilities to RNA-ISH.”

Visiopharm’s Oncotopix® Discovery software enables users to explore complex tissue data intuitively and customize analyses to fit their specific experimental needs. Its advanced exploratory capabilities enhance analysis accuracy in complex tissue samples. The ability to develop custom deep-learning-based segmentation algorithms, which can account for both cellular and nuclear morphology, enables more precise quantification of RNA. This marks a significant improvement over traditional methods, which often struggle with complex or irregular structures, such as a nuclear or multinucleate cells, leading to missed or inaccurate counts.

“At Visiopharm, our mission is to empower researchers with advanced tools that deliver unmatched precision in image analysis,” said Regan Baird, Senior Vice President, Commercial Strategy Deployment of Visiopharm. “Partnering with Molecular Instruments allows us to elevate the standard of RNA-ISH analysis, integrating our Oncotopix® Discovery software with MI’s HCR™ technology to provide researchers with an unprecedented level of accuracy and efficiency. We are excited to collaborate and advance the field of precision pathology, accelerating breakthroughs in disease research and diagnostics.”

This partnership marks a pivotal advancement in research, combining high-performance, clinical-grade RNA-ISH with sophisticated image analysis. Together, we are equipping scientists to drive breakthroughs in disease studies, offering deeper insights into gene expression and protein interactions. By integrating our innovative technologies, we aim to accelerate discoveries across translational medicine, where accurately and precisely understanding gene and protein expression are essential.

About Molecular Instruments: 
Molecular Instruments® (www.hcrimaging.com) develops and synthesizes molecular kits powered by the breakthrough HCR™ imaging platform for applications in academic research, drug development, synthetic biology, and clinical pathology and diagnostics.

About Visiopharm: 
Visiopharm is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with no fewer than nine diagnostic algorithms cleared under IVDR for EU and UK customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows. Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company’s headquarters are located in Denmark’s Medicon Valley, with legal entities in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.
For more information visit visiopharm.com.

Media Contact: Joyce Yoo, Associate Director of Marketing, joyce@molecularinstruments.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/molecular-instruments-and-visiopharm-announce-strategic-partnership-to-combine-ai-driven-precision-pathology-with-hcr-pro-assays-to-advance-clinical-grade-rna-ish-302297058.html

SOURCE Molecular Instruments

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Arjo and Bruin Biometrics conclude distribution agreement, Bruin Biometrics resumes direct sales and marketing of Provizio® SEM Scanner

Published

on

By

LOS ANGELES and LONDON, Nov. 6, 2024 /PRNewswire/ — Today Bruin Biometrics and Arjo announce the immediate transition of direct sales and marketing of the Provizio® SEM Scanner to Bruin Biometrics, following four years of cooperation between the companies.

As communicated earlier this year, the companies decided not to extend the distribution agreement for the Provizio SEM Scanner. Accordingly, and effective today, all sales and marketing of the Provizio SEM Scanner products transition from Arjo to Bruin Biometrics. Both companies remain fully committed to supporting customers throughout the process to ensure a continued high level of customer service.

“Supporting Provizio SEM Scanner users’ work to achieve a zero incidence of preventable pressure injuries in all care settings is our top priority and we look forward to supporting Provizio SEM Scanner users directly to help overcome this challenge,” commented Bruin Biometrics’ CEO, Martin Burns.

“Pressure injuries represent a significant economic challenge for healthcare systems worldwide, and Arjo has extensive experience in both prevention and treatment within this area. We see a growing interest for our other solutions and are fully committed to continue supporting our customers in their efforts to prevent pressure injuries,” says Joacim Lindoff, President & CEO of Arjo.

For more information about Bruin Biometrics, please contact:
Kate Hancock, EVP External Communications, Bruin Biometrics Tel: +447827315347
Email: khancock@bruinbiometrics.com

Media contact details:
Joanna Dodd, Alicia Barkle Rochester PR Group: joanna.dodd@rochesterprgroup.com, alicia.barkle@rochesterprgroup.com 

ABOUT Bruin Biometrics

Bruin Biometrics LLC is a pioneer in modernizing healthcare with biometric sensor technology for early detection and monitoring of chronic, preventable conditions in collaboration with clinicians. Bruin Biometrics work on SEM Assessment Technology has been recognized with multiple global healthcare innovation awards and is implemented in healthcare facilities across a variety of care settings. Bruin Biometrics HQ is based in Los Angeles, USA.

Photo – https://mma.prnewswire.com/media/2549409/Provizio_SEM_Scanner.jpg
Logo – https://mma.prnewswire.com/media/3604/BRUIN_BIOMETRICS1__LLC_LOGO.jpg

View original content:https://www.prnewswire.co.uk/news-releases/arjo-and-bruin-biometrics-conclude-distribution-agreement-bruin-biometrics-resumes-direct-sales-and-marketing-of-provizio-sem-scanner-302297639.html

Continue Reading

Technology

Opus IVS and Protech Automotive Solutions Announce Collaboration on Industry-Leading ADAS Identification Solution

Published

on

By

DEXTER, Mich., Nov. 6, 2024 /PRNewswire/ — Opus IVS, a global leader in intelligent vehicle support solutions, is pleased to announce a new partnership with Protech Automotive Solutions, the largest national provider of Advanced Driver-Assistance System (ADAS) diagnostic scanning and calibration services, which will enhance Opus IVS’s ADAS MAP (Advanced Driver Assistance Systems Mapping) solution. This collaboration will deliver extensive ADAS identification capabilities, combining the advanced ADAS technologies of both companies – with Opus IVS licensing Protech’s ADAS ID3 technology to bring new innovations to the industry-leading ADAS MAP platform.

The Opus IVS and Protech partnership will create a seamless ADAS identification solution that enables technicians to quickly and accurately identify ADAS systems, empowering repair shops to make well- informed repair and calibration decisions. With Protech Automotive Solutions, the nation’s largest car- side provider, this partnership will offer an enhanced solution to power leading U.S. multi-shop operators (MSOs). Additionally, Opus IVS recently announced that major insurers now recognize ADAS MAP’s accuracy, which leads to increased reimbursement for repair shops and adds significant value for the industry.

“This collaboration between Opus IVS and Protech represents a breakthrough in delivering accessible ADAS insights,” said Brian Herron, CEO of Opus IVS. “By joining forces, we’re building a more powerful ADAS solution for collision shops, allowing them to serve their customers with the highest levels of accuracy and safety.”

Grant LaBarbera, GM and Senior Vice President of Protech, added, “We’re excited to partner with Opus IVS to enhance the industry’s capabilities in ADAS identification. This collaboration brings together the best of both companies’ innovations and will improve the way repair shops approach ADAS, driving greater accuracy, quality and consistency across the industry.”

About Opus IVS
Opus IVS provides diagnostic and programming support to over 50,000 workshops globally. With a suite of solutions for complex repairs and ADAS management, Opus IVS empowers shops to deliver accurate repairs using advanced technology, OE support, and live technician guidance.

About Protech Automotive Solutions
With the largest national footprint of Advanced Driver-Assistance System (ADAS) diagnostic scanning and calibration services, Protech Automotive Solutions is the leading provider of advanced diagnostics, calibrations and ADAS solutions for collision repair shops. Protech is committed to vehicle safety through innovative, reliable ADAS technology and offers expertise that helps automotive service providers keep their customers safe. More than 1,200 Protech technicians, across 41 states and growing, are expertly trained to scan, calibrate and diagnose vehicles during collision, auto glass and mechanical repairs, ensuring that complex systems like ADAS are restored to their proper function.

For more information, please visit www.protechautomotivesolutions.com.

For more information:
Justin Baronoff
Merit Mile
561-362-8888 – office
407-340-2247 – mobile
jbaronoff@meritmile.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/opus-ivs-and-protech-automotive-solutions-announce-collaboration-on-industry-leading-adas-identification-solution-302297790.html

SOURCE Opus IVS

Continue Reading

Technology

Retail Fluent Media Network Announces Strategic Partnership with Save A Lot’s Independent Retail Partners

Published

on

By

Nearly 900 Stores to Utilize RFMN’s Dynamic, Ultra-Bright Digital Window Signs™ for Advertising; Number of Screens Projected to Double by End of Q4, 2024

LITTLE FALLS, N.J., Nov. 6, 2024 /PRNewswire-PRWeb/ — Retail Fluent Media Network (RFMN), a top retail media and ad tech company that caters to independent grocers, mid- to large-scale chain supermarkets, and convenience stores, has revealed a new strategic partnership with Save a Lot’s independent Retail Partners. This partnership includes Save a Lot’s 750 independently owned and operated stores located across 32 states in the United States.

Through this partnership, Save a Lot’s independent Retail Partners will have the opportunity to utilize Digital Window Signs™ to promote weekly sales programs, special events, promotional items, and more. RFMN has already installed 400 digital screens in almost 100 Save a Lot stores, with plans to double the number of active Digital Window Signs™ by Q1, 2025.

“We’re thrilled to partner with Save a Lot’s independent Retail Partners to bring the power of our dynamic Digital Window Signs™ and an industry-leading ad tech platform to their extensive network of stores across the United States,” stated Joni Elmore, Chief Commercial Officer at Retail Fluent Media Network “This collaboration empowers local grocers to enhance their in-store advertising with real-time promotions and elevate engagement with customers and CPG partners. We look forward to giving more stores the opportunity to differentiate themselves in their market with stunning visuals.”

In addition to next-level digital signage, Retail Fluent Media Network provides end-to-end services for Save a Lot’s independent Retail Partners. RFMN manages the content shared by the Save a Lot, working with its vast network of artists and graphic designers, and launching dynamic advertisements through its proprietary ad tech platform to align with each location’s sales and promotions schedule. This allows Save a Lot’s independent Retail Partners to focus on business operations and meeting customer needs.

Retail Fluent Media Network has recently announced its spinoff from Retail Fluent, a prominent retail innovation, design, and décor firm. This decision was made in response to the high demand and growth of the company. RFMN currently owns and operates almost 5,000 Digital Window Signs™ in 28 states, with plans to more than double this number by the end of 2025.

About Retail Fluent Media Network:

Retail Fluent Media Network is a leading retail media and ad tech company for independent grocers, mid- to large-scale chain supermarkets and convenience stores. The company’s digital out-of-home (DOOH) model utilizes ultra-bright LCD and LED screens proven to attract attention to static or video advertisements. Beneficial for both grocers and CPG brands, RFMN’s expanding network already delivers over 50 million impressions weekly and over 200 million monthly to its advertising partners. To partner, advertise, or learn more, visit https://www.retailfluentmedia.com.

Media Contact

Javian Pereira, Fastlane Communications, 1 9736683003, javian@fastlane.co

View original content:https://www.prweb.com/releases/retail-fluent-media-network-announces-strategic-partnership-with-save-a-lots-independent-retail-partners-302296168.html

SOURCE Retail Fluent Media Network

Continue Reading

Trending